Please sign in to follow a disease.
Myoclonic epilepsy
MONDO:0100577A group of epilepsy syndromes in which myoclonic seizures are a prominent feature.
Also known as: myoclonic epilepsy syndrome
23 clinical trials for this condition and its sub-types, 1 tagged with Myoclonic epilepsy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Myoclonic epilepsy
-
Progressive myoclonus epilepsy 5 trials · 12 incl. sub-types
15 sub-types
- MERRF syndrome 5 trials
- Lafora disease 1 trial Sub-types →
- Unverricht-Lundborg syndrome 1 trial
- Neuronal ceroid lipofuscinosis 8 northern epilepsy variant 1 trial
- Action myoclonus-renal failure syndrome 0 trials
- Early-onset Lafora body disease 0 trials
- Epilepsy, progressive myoclonic, 11 0 trials
- Epilepsy, progressive myoclonic, 12 0 trials
- Epilepsy, progressive myoclonic, 1B 0 trials
- Familial encephalopathy with neuroserpin inclusion bodies 0 trials
- Progressive myoclonic epilepsy type 3 0 trials
- Progressive myoclonic epilepsy type 6 0 trials
- Progressive myoclonic epilepsy type 7 0 trials
- Progressive myoclonic epilepsy type 8 0 trials
- Progressive myoclonic epilepsy type 9 0 trials
-
Juvenile myoclonic epilepsy 3 trials
1 sub-type
- Myoclonic epilepsy, juvenile, 2 0 trials
-
Epilepsy, familial adult myoclonic 0 trials
8 sub-types
- Benign adult familial myoclonic epilepsy 0 trials
- Epilepsy, familial adult myoclonic, 1 0 trials
- Epilepsy, familial adult myoclonic, 2 0 trials
- Epilepsy, familial adult myoclonic, 3 0 trials
- Epilepsy, familial adult myoclonic, 4 0 trials
- Epilepsy, familial adult myoclonic, 5 0 trials
- Epilepsy, familial adult myoclonic, 6 0 trials
- Epilepsy, familial adult myoclonic, 7 0 trials
-
Myoclonic epilepsy in infancy 0 trials
-
Myoclonic epilepsy, Hartung type 0 trials
Most studied deeper sub-types
-
New drug aims to tame hard-to-control seizures in rare mitochondrial disorders
Disease control Stopped earlyThis study tested a drug called vatiquinone in 68 people with mitochondrial disease and epilepsy that doesn't respond to standard treatments. Participants were randomly assigned to receive either vatiquinone or a placebo for 24 weeks to see if the drug could reduce the number of …
Phase 2/3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Epilepsy drug study halted early: BHV-7000 shows limited promise
Disease control Stopped earlyThis study tested whether BHV-7000, taken alongside other medications, could reduce generalized tonic-clonic seizures in people with idiopathic generalized epilepsy. The trial was terminated early and enrolled only 27 adults aged 18-75. The main goal was to see how long it took f…
Phase 2/3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Dravet syndrome drug trial halted early: did lorcaserin help?
Disease control Stopped earlyThis study tested whether lorcaserin, when added to current medications, could reduce convulsive seizures in people with Dravet syndrome, a severe form of epilepsy. The trial planned to enroll about 22 participants aged 2 and older, but it was terminated early. The main goal was …
Phase 3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC